Biyoteknoloji

How CRISPR Is Curing the Incurable – The Gene Editing Revolution Transforming Medicine
 ·  ·  · 

CRISPR Nasıl Tedavi Edilemeyeni Tedavi Ediyor – Tıbbı Dönüştüren Gen Düzenleme Devrimi

2012 yılında, Jennifer Doudna ve Emmanuelle Charpentier, CRISPR/Cas9’un test tüplerinde DNA düzenlemek için yeniden kullanılabileceğini gösteren çığır açıcı bir makale yayımladı. 2013 yılında, Feng Zhang liderliğindeki laboratuvarlar, CRISPR’ın canlı ökaryotik hücreler içinde genleri düzenleyebileceğini gösterdi. 2019 yılında, ilk ABD CRISPR denemesi orak
Eylül 6, 2025

Technology News

  • Prediction: IBM Could Be 2026's Biggest Quantum Stock Winner
    December 7, 2025, 9:44 PM EST. Amid rapid quantum progress, IBM is positioned to be the standout winner in 2026. After a turbulent decade, the company has pivoted toward cloud and AI while advancing its quantum roadmap, from early access in 2016 to the IBM Q System One and the recent Nighthawk 120-qubit processor. IBM's promise of quantum advantage by 2026 and a planned fault-tolerant quantum computer by 2029 highlights a multi-year strategy. Financially, IBM posted solid growth in the first nine months of 2025 with nearly $48 billion revenue and about $5.0 billion net income, supporting a stable foundation even as some competitors soar. Critics may note the P/E multiple and still-developing earnings from quantum, but IBM's profits and ongoing quantum investments keep it in the spotlight.
  • Generative AI Upside: Palantir and Innodata Could Triple Revenue in 5 Years
    December 7, 2025, 9:42 PM EST. Two software plays, Palantir (PLTR) and Innodata (INOD), look to ride the generative AI boom alongside chipmakers. Palantir operates Gotham and Foundry, integrating data for government and commercial clients to spot trends. Innodata provides AI-data prep microservices that clean and annotate training data as firms scale AI projects. From 2020 to 2024, Palantir's revenue grew at a 27% CAGR to about $2.9B and it turned GAAP profitable in 2023, helping it join the S&P 500. Innodata delivered roughly 31% CAGR, rising from $58M to $170M as major tech firms rely on its prep tools. The piece weighs which could deliver bigger five-year revenue gains and which stock looks best today.
  • Nvidia CEO Huang: China Could Beat US in AI Due to Fast Infrastructure and Energy Growth
    December 7, 2025, 9:32 PM EST. Nvidia CEO Jensen Huang warned that while the United States remains ahead in AI-chip technology, China's rapid infrastructure growth and expanding energy capacity could tilt the race. Speaking at CSIS, Huang contrasted a three-year timeline to build a data center in the United States with China's ability to 'build a hospital in a weekend.' He noted China's larger energy base, arguing the edge matters even as Nvidia remains 'generations ahead' on chips. Huang cautioned against underestimating China's manufacturing and infrastructure prowess, even as United States and UK policy environments shape progress. The broader debate among tech leaders centers on how policy, energy constraints, and infrastructure will determine international leadership in artificial intelligence.
  • NVIDIA GTC 2026 Returns to San Jose in March to Unveil AI's Next Wave
    December 7, 2025, 9:30 PM EST. NVIDIA confirms GTC 2026 will run March 16-19, 2026 in San Jose with a livestreamed keynote by CEO Jensen Huang and a slate of AI announcements. Coming two months after CES, the event will spotlight the "next wave of AI innovation," from physical AI and AI factories to agentic AI and inference. NVIDIA also previewed its two-year AI roadmap, including Vera Rubin NVL144 for H2 2026 and Rubin Ultra NVL576 planned for 2027. The company has shown the Blackwell RTX Pro and the Blackwell Ultra GB300 with 288GB of HBM3e, enabling up to 1.1 exaFLOPS of FP4 compute. Workshops will cover accelerated AI infrastructure, sovereign AI, LLMs, and neural agents across data types.
  • Will Tesla Stock Pop or Drop in 2026? AI Push, Robotaxis, and Valuation Questions
    December 7, 2025, 9:26 PM EST. Tesla's 2025 run has been volatile: up about 9% through Dec. 3 but lagging the S&P 500's 16%. The company faces questions heading into 2026 as it leans into being an AI-focused business while its EV sales plateau. Controversies around Elon Musk and past ties to DOGE, plus the debate over a sky-high valuation (roughly a P/E around 300 with only modest GAAP profits) keep investors cautious. Third-quarter results showed revenue up 12% to $28.1B, but both GAAP and adjusted EPS fell sharply due to higher R&D and other costs tied to the Optimus robot and the expansion of its robotaxi network. Bulls point to AI upside; skeptics warn that 2026 could resemble 2025: big promises, little near-term growth.